Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

7.1K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

9.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

7.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TREM1 signaling amplifies neutrophil-mediated inflammation in inflammatory bowel disease.

Nature communications·2026
Same author

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease.

Frontiers in immunology·2026
Same author

Effects of a 12-week Tai Chi program on postural stability and gait biomechanics in prefrail older adults: a randomized controlled study.

Journal of neuroengineering and rehabilitation·2026
Same author

Effects of Tai Chi Chuan on Postural Stability and Lower-Limb Biomechanical Characteristics in Patients With Functional Ankle Instability: A Randomized Controlled Trial.

Archives of rehabilitation research and clinical translation·2026
Same author

Effects of graded talar external rotation on distal tibial articular surface stress and contact pressure: a finite element study.

Frontiers in sports and active living·2026
Same author

Development of LRRC15-binding disulfide-constrained peptides for PET imaging of cancer-associated fibroblasts.

Nature communications·2026

Related Experiment Video

Updated: Mar 27, 2026

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.6K

A modular platform for Sterically Masked Activated Cytokines (SMACks).

Travis J Morgenstern1, Naruhisa Ota2, Zhonghua Lin1

  • 1Department of Antibody Engineering, Genentech Inc., South San Francisco, CA 94080.

Proceedings of the National Academy of Sciences of the United States of America
|March 25, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed a modular Sterically Masked Activated Cytokine (SMACk) platform for targeted cytokine delivery. This approach enables precise control over cytokine activity, enhancing therapeutic potential and reducing side effects.

Keywords:
cytokineprotein engineeringtargeted delivery

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K
Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

46.3K

Related Experiment Videos

Last Updated: Mar 27, 2026

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.6K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K
Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

46.3K

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Cytokines are crucial signaling molecules with broad therapeutic potential, but their clinical application is limited by pleiotropic effects.
  • Existing methods for developing conditionally active cytokines are complex and restrict applicability to a few candidates.

Purpose of the Study:

  • To introduce a simple, modular Sterically Masked Activated Cytokine (SMACk) platform for targeted cytokine delivery.
  • To demonstrate the efficacy of the SMACk format using interleukin-22 (IL-22) and interferon-alpha (IFN-α).

Main Methods:

  • Engineered a modular format by assembling a targeting antibody fragment (Fab/VHH), cytokine, and Fc domain.
  • Developed an IL-22 SMACk targeting intestinal epithelial cells, analyzing its cis-signaling mechanism and tunable parameters.
  • Tested the IL-22 SMACk in a mouse colitis model and demonstrated broader applicability with other cytokines like IFN-α, IL-2, IL-4, and IL-7.

Main Results:

  • The IL-22 SMACk exhibited selective activity in the colon and demonstrated therapeutic efficacy in a colitis model.
  • The SMACk platform allows for tunable parameters and a reduced on-rate, facilitating cis-signaling.
  • The platform was successfully adapted to target CD8+ T cells with various cytokines, including IFN-α, IL-2, IL-4, and IL-7.

Conclusions:

  • The SMACk platform offers a versatile and simple approach to engineer conditionally active cytokines.
  • This technology has the potential to overcome limitations of current cytokine therapies and advance their clinical applications.
  • SMACks can be readily adapted to target specific cell types, broadening the scope of cytokine-based therapeutics.